Document is current
Any future updates will be listed below
-
Authors
Wu, Xiaowu
Cap, Andrew P.
Bynum, James A.
Chance, Tiffani C.
Darlington, Daniel N.
Meledeo, Michael A.
-
Funding
Funding for this research was provided by:
U.S. Army Medical Research and Development Command (B_018_2020)
- License Information
-
More Information
Article History
Received: 4 October 2023
Accepted: 7 February 2024
First Online: 16 February 2024
Competing interests
: A patent was filed: ISR 22-04-US01-PRI: 63/379,518 filed 14 Oct 2022, “Prolyl Hydroxylase Domain Inhibitor Treatment to Improve Survivability of Hemorrhagic Shock” by Andrew P. Cap, James A. Bynum, and Xiaowu Wu from U.S. Army Institute of Surgical Research. The authors declare no competing interests.
